CVS Health (CVS)
NYSEHealth CareHealthcare PlansSnapshot 2026-07-08
$104.44+0.11%
Close 2026-07-08 · 1-day change
Reading CVS? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track CVS free→NYSEHealth CareHealthcare PlansSnapshot 2026-07-08
Reading CVS? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track CVS free→QuarterlyIQ Insights · CVS
Material updates from SEC filings (8-K, 10-Q, 10-K) ranked by impact, with no firehose noise.
The filing is about the approval of a new compensation plan, not a management change.
by reference. The information in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (as amended, the “Exchange Act”) or otherwise subject to the liabilities of that Section, and shall not be or be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing, except as shall…
Director — John E. Gallina: John E. Gallina was elected to the Board of Directors and appointed to the Audit Committee.
by reference. The information in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (as amended, the “Exchange Act”) or otherwise subject to the liabilities of that Section, and shall not be or be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing, except as shall…
by reference. The information in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (as amended, the “Exchange Act”) or otherwise subject to the liabilities of that Section, and shall not be or be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing, except as shall…
Other Events. On September 22, 2025, Omnicare, LLC (“Omnicare”), a wholly owned indirect subsidiary of CVS Health Corporation (NYSE: CVS), issued a press release announcing that Omnicare and certain of its subsidiary entities (the “Omnicare Entities”) have voluntarily initiated chapter 11 proceedings under the U.S. Bankruptcy Code, in order to resolve issues related to its recent litigation in the U.S. District Court for the Southern District of New York (the “District Court”), in which the D…
Other Events. On August 11, 2025, CVS Health Corporation, a Delaware corporation (the “Company”), entered into an Underwriting Agreement (the “Underwriting Agreement”) with Barclays Capital Inc., J.P. Morgan Securities LLC and Wells Fargo Securities, LLC as representatives of the several underwriters named in Schedule I thereto (collectively, the “Underwriters”), pursuant to which the Company agreed to issue and sell to the Underwriters $750,000,000 aggregate principal amount of its 5.000% Se…
by reference. The information in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (as amended, the “Exchange Act”) or otherwise subject to the liabilities of that Section, and shall not be or be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing, except as shall…
by reference. The information in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (as amended, the “Exchange Act”) or otherwise subject to the liabilities of that Section, and shall not be or be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing, except as shall…
Chief Financial Officer — Brian O. Newman: Appointment of Brian O. Newman as Executive Vice President and Chief Financial Officer.
by reference. The information in this Current Report on Form 8-K shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (as amended, the “Exchange Act”) or otherwise subject to the liabilities of that Section, and shall not be or be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing. Section 9 - Financial Statements and Exh…
Other Events On December 16, 2024, CVS Health Corporation, a Delaware corporation (the “Company”), issued press releases announcing the (A) early results and election of early settlement and (B) pricing, respectively, of its cash tender offer (the “Maximum Tender Offer”) for the maximum principal amount of the following series of Maximum Tender Offer Notes (as defined below) for which the aggregate purchase price, not including accrued interest, payable in respect of such Maximum Tender Offer…
Other Events On December 9, 2024, CVS Health Corporation, a Delaware corporation (the “Company”), issued a press release announcing the expiration and tender results of its cash tender offer for any and all of its 4.100% Senior Notes due 2025, in connection with the Company’s previously announced cash tender offers commenced on December 2, 2024. A copy of the press release is attached hereto as Exhibit 99.1, which is incorporated by reference herein. Section 9 - Financial Statements and Exhibits
Other Events. On December 6, 2024, CVS Health Corporation, a Delaware corporation (the “Company”), issued a press release announcing the pricing of its cash tender offer for any and all of its 4.100% Senior Notes due 2025, in connection with the Company’s previously announced cash tender offers commenced on December 2, 2024. A copy of the press release is attached hereto as Exhibit 99.1, which is incorporated by reference herein. Section 9 - Financial Statements and Exhibits
Other Events. On December 3, 2024, CVS Health Corporation, a Delaware corporation (the “Company”), entered into an Underwriting Agreement (the “Underwriting Agreement”) with Barclays Capital Inc., Citigroup Global Markets Inc. and Goldman Sachs & Co. LLC, as representatives of the several underwriters named in Schedule I thereto (collectively, the “Underwriters”), pursuant to which the Company agreed to issue and sell to the Underwriters $2,250,000,000 aggregate principal amount of its 7.000%…
Other Events. On December 2, 2024, CVS Health Corporation, a Delaware corporation, issued a press release announcing the commencement of cash tender offers for (1) any and all of its 4.100% Senior Notes due 2025 (the “Any and All Notes”), and (2) the maximum principal amount of the following series of notes for which the aggregate purchase price, not including accrued interest, payable in respect of such notes, does not exceed $2,000,000,000 less the aggregate purchase price, not including ac…
The excerpt is incomplete and does not provide specific details about the movement or event.
is incorporated herein by reference. On November 17, 2024, Ms. Norwalk, Mr. Robbins, Mr. Sansone and Mr. Shulman were appointed to the Board. In connection with the appointments of Mr. Robbins, Ms. Norwalk, Mr. Sansone and Mr. Shulman, the size of the Board was increased from 12 to 16 members. Ms. Norwalk was appointed to the HS&T Committee of the Board, Mr. Sansone was appointed to the Audit Committee of the Board and Mr. Shulman was appointed to the Management Planning and Development (“MP&…
Executive Vice President and Group President — Prem S. Shah: Prem S. Shah was promoted to a newly created senior position within the company.
by reference. The information in this Current Report on Form 8-K shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (as amended, the “Exchange Act”) or otherwise subject to the liabilities of that Section, and shall not be or be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing. Section 9 - Financial Statements and Exh…
and this Item 7.01, including Exhibit 99.1, shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. The information in
President and Chief Executive Officer — J. David Joyner: J. David Joyner was promoted to President and Chief Executive Officer, replacing Karen S. Lynch.
by reference. The information in this Current Report on Form 8-K shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (as amended, the “Exchange Act”) or otherwise subject to the liabilities of that Section, and shall not be or be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing. Section 9 - Financial Statements and Exh…
The filing is about amendments to the company's incentive compensation plan, not a management change.
Other Events. On May 9, 2024, CVS Health Corporation, a Delaware corporation (the “Company”), issued and sold $1,000,000,000 aggregate principal amount of the Company’s 5.400% Senior Notes due 2029 (the “2029 Notes”), $1,000,000,000 aggregate principal amount of the Company’s 5.550% Senior Notes due 2031 (the “2031 Notes”), $1,250,000,000 aggregate principal amount of the Company’s 5.700% Senior Notes due 2034 (the “2034 Notes”), $750,000,000 aggregate principal amount of the Company’s 6.000%…
General market headlines, full earnings-call transcripts, and macro and sector developments flagged when they directly affect this stock are on the way. Today this tab covers SEC filings.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.